We Know Psychiatry Archives - Page 20 of 27

Use of Acetaminophen During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder

By MedWorks|2016-03-29T15:42:37-07:00March 29th, 2016|We Know Psychiatry|

ABSTRACT Prenatal exposure to acetaminophen may result in compromised neurodevelopment through inflammatory and immunologic mechanisms, through predisposition to oxidative stress, and through endocrine, endogenous cannabinoid, and other mechanisms. Several small and large prospective studies have found an association between gestational acetaminophen exposure and attention-deficit/hyperactivity disorder (ADHD)-like behaviors, use of ADHD [...]

0

The Saga of Genetics: When Mental Illness Runs in the Family

By James La Rossa|2016-03-28T17:35:44-07:00March 28th, 2016|We Know Psychiatry|

For anyone who has had the great pleasure of reading Siddhartha Mukherjee's 2011 Pulitzer Prize winning "The Emperor of All Maladies: A Biography of Cancer," expect something very special when Dr. Mukherjee's next book, " The Gene: An Intimate History," is published in the Spring. Writing in the March 28, 2016 [...]

0

Risky, Addictive Behavior the Study of New Stanford Research

By MedWorks|2016-03-24T16:58:48-07:00March 24th, 2016|We Know Psychiatry|

A prominent Stanford neuroscientist and psychiatrist, and his colleagues gives some clues about what makes some people risk-averse and others risk-taking. Answers could have implications for how to treat, curb or prevent destructively risky behavior, like pathological gambling or drug addiction.. The study, published Wednesday in the journal Nature, reports [...]

0

NUTRITIONAL DRINK MAY HELP REDUCE BRAIN SHRINKAGE AND SLOW SYMPTOMS OF ALZHEIMER’S DISEASE, EU STUDY SHOWS

By James La Rossa|2016-03-15T16:20:17-07:00March 15th, 2016|We Know Psychiatry|

In a recent study, researchers looked at the possibility of using nutritional intervention to slow the onset of certain Alzheimer’s symptoms. The study involved a particular nutritional drink called Souvenaid http://www.souvenaid-us.com/, which was given to patients in the pre-dementia (prodromal) stage of Alzheimer’s once a day for a twelve month [...]

0

Marijuana-Based Drug Found to Reduce Epileptic Seizures

By MedWorks|2016-03-15T01:21:47-07:00March 15th, 2016|We Know Psychiatry|

The New York Times will report tomorrow that an experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced on Monday, a finding that could lend credence to the medical marijuana movement. The developer, GW Pharmaceuticals, Epidiolex, achieved the [...]

0

Psychopharmacology Bulletin Pens Ventures with EbscoHost, Elsevier, and Bio-Press; 2016 Issues, Set for Index Medicus, are In Press

By James La Rossa|2016-03-05T22:18:10-08:00March 5th, 2016|We Know Psychiatry|

For Immediate Release March 7, 2016. Los Angeles CA Contact: James La Rossa Jr., 310.374.1300 2016 Issues, Set for Index Medicus, are In Press Psychopharmacology Bulletin — reactivated by the National Library of Medicine — has finalized a series of agreements with the largest repositories of acquisitions medical libraries. Bulletin [...]

0

Open Access Research Sheds Light On Pharmacologic Treatment for Two Disorders

By MedWorks|2016-03-05T18:09:08-08:00March 5th, 2016|We Know Psychiatry|

Antipsychotic Management of Schizoaffective Disorder: A Review Jean-Pierre Lindenmayer, and Amandeep Kaur The Cost Effectiveness of Limsdexamafetamtine Dimesylate for the Treatment of Binge Eating Disorder in the USA Tama ́sA ́gh

0

Medical Advertising in the Crosshairs

By James La Rossa|2016-02-29T16:31:12-08:00February 29th, 2016|We Know Psychiatry|

In the summer of 1997, I was months away from launching the first consumer magazine about mental illness. My company had acquired a state and federal trademark for the title, Mental Fitness (The Science of Mental Wellness). I had done a long interview with the veteran 60 Minutes journalist, Mike [...]

0

Postpartum Depressed Penalized by Insurance Companies

By James La Rossa|2016-02-27T18:17:23-08:00February 27th, 2016|We Know Psychiatry|

Other than the obvious onset of the mental disorder itself, postpartum depression is one of those illnesses that is hard to predict, and according to published records, may be even harder to insure against. After a government panel recommended that pregnant women be screened for depression, life and disability insurance [...]

0

Commonly Used P.P.I.s Tied to Brain Disease

By James La Rossa|2016-02-23T20:20:29-08:00February 23rd, 2016|We Know Psychiatry|

Proton Pump Inhibitor's (or P.P.I.s), widely available by prescription or over the counter brands like Prevacid, Nexium, and Prilosec, have been tied to Alzheimer's Disease and other dementias, according to German researchers writing in JAMA Neurology. The researchers looked for five years at 73,679 men and women over 75 who were [...]

0